Topic: Icon Study

1 chapters across the catalog

Dr. Peter McCullough argues that the FDA committed malfeasance by discouraging the use of ivermectin, which he claims was a proven therapeutic for COVID-19. He cites the ICON study as evidence that ivermectin reduced mortality in hospitalized patients. McCullough suggests that the FDA's actions, including labeling the drug as "horse paste," led to unnecessary deaths and should result in class-action lawsuits.